Yoori Lee joins Beyond Air board, bringing MEDACorp expert-network roots

Yoori Lee has joined the board of Beyond Air Inc. (NASDAQ: XAIR) as a director, according to the company's website. Her appointment adds a name with deep roots in the healthcare expert-network business to a small-cap medical device firm.

Lee's biography on Beyond Air's site identifies her most recent role as Trio Health, with her prior tenure at Leerink Partners LLC running over 15 years. Leerink is a healthcare-focused investment bank whose research franchise leans heavily on MEDACorp, the in-house expert network it operates as a differentiator against bulge-bracket coverage.

MEDACorp itself is a notable footnote in the expert-network landscape. Most of the named players, GLG, Guidepoint, Third Bridge, AlphaSense/Tegus, are independent firms selling to a wide buy-side base. MEDACorp is different: it sits inside an investment bank and primarily services that bank's research and banking workflows, with the same compliance overhead and a healthcare-only roster. According to the Beyond Air bio, the network includes more than 35,000 professionals across clinical medicine, biomedical research, regulatory affairs, public policy, healthcare administration, and health IT.

Beyond Air, for its part, is a commercial-stage medical device and biopharmaceutical company. The board appointment slots a former senior executive of a healthcare expert network onto the governance side of a company whose business depends on the same kind of clinical and regulatory expertise that MEDACorp specialists are paid to provide.

Neither Beyond Air nor Lee has, on the company's bio page, disclosed the timing or terms of the appointment. Investors looking for a fuller picture should watch the next 8-K filing.